| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | $4.3B | $3.6B | $3.7B | $0.3B | $1.4B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | $0.1B | $0.3B |
| R&D Expense | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.0B | $0.1B |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $0.8B | $0.9B | $0.8B | $0.4B | $0.1B | $-1.5B | $0.0B | $-2.1B |
| Net Income | $0.4B | $0.5B | $0.4B | $0.0B | $-0.5B | $-1.9B | $-0.0B | $-2.1B |
| EPS (Basic) | $5.96 | $6.93 | $5.79 | $0.37 | — | — | — | — |
| EPS (Diluted) | $5.93 | $6.75 | $5.66 | $0.36 | — | — | — | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $5.2B | $5.2B | $5.1B | $4.7B | $4.8B | $5.4B | $7.3B | $6.6B |
| Current Assets | $3.4B | $3.4B | $3.3B | $3.0B | $2.9B | $3.2B | $3.5B | $3.5B |
| Cash & Equivalents | $1.0B | $0.9B | $1.0B | $0.9B | $1.0B | $1.1B | $0.6B | $0.6B |
| Total Liabilities | $3.5B | $3.9B | $4.1B | $4.2B | $4.3B | $4.5B | $4.4B | $10.3B |
| Current Liabilities | $1.5B | $1.7B | $1.9B | $1.5B | $1.3B | $1.4B | $1.7B | $2.3B |
| Stockholders' Equity | $1.7B | $1.3B | $0.9B | $0.5B | $0.5B | $0.9B | $2.9B | $-3.7B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.7B | $0.8B | $0.8B | $0.3B | $0.3B | $0.2B | $0.1B | $-0.2B |
| Investing Cash Flow | $-0.1B | $-0.3B | $-0.3B | $-0.1B | $-0.1B | $-0.1B | $-0.0B | $0.1B |
| Capital Expenditures | $0.2B | $0.3B | $0.2B | $0.1B | $0.1B | $0.2B | $0.0B | $0.2B |
| Financing Cash Flow | $-0.5B | $-0.5B | $-0.5B | $-0.2B | $-0.4B | $0.3B | $-0.0B | $0.2B |